Parvoruvax inj. susp. i.m. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Erysipelothrix rhusiopathiae (inactivated) >= 1 ELISA U/dose; Porcine parvovirus (inactivated)
Available from:
Ceva Santé Animale SA-NV
ATC code:
QI09AL01
Pharmaceutical form:
Suspension for injection
Administration route:
Intramuscular use
Therapeutic area:
Porcine Parvovirus + Erysipelothrix
Product summary:
CTI Extended: 570933-01
Authorization status:
Commercialised: Yes
Authorization date:
2020-09-09
